The Patent Finder

Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis, and Other Disorders

Miralogx LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,760,039Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis, and Other Disorders
In force
 · Medium confidence
Miralogx LLCIn forceMedium confidence
Application 19/416,585Zinc Co-Therapies for Treating Autoimmune Disorders, Bacterial Infections and Viral Infections
Pending
Not granted
Miralogx LLCPendingNot granted
Application 19/648,753Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis and Other Disorders
Pending
Not granted
Miralogx LLCPendingNot granted
Application 19/650,023Anti-Inflammatory Compounds, Pharmaceutical Compositions, and Methods of Treating Hemochromatosis and Other Disorders
Pending
Not granted
Miralogx LLCPendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Miralogx LLC.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited